USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 28,788 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $57.19, for a total transaction of $1,646,385.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

USANA Health Sciences, Inc. (NYSE:USNA) traded down 0.61% during mid-day trading on Friday, hitting $57.00. 185,419 shares of the stock were exchanged. The stock has a 50 day moving average of $57.61 and a 200-day moving average of $60.16. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $75.00. The stock has a market cap of $1.39 billion, a price-to-earnings ratio of 14.81 and a beta of 1.10.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, July 25th. The company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.06 by ($0.08). The firm had revenue of $257.10 million during the quarter, compared to the consensus estimate of $273.61 million. USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The business’s revenue was down .5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.07 earnings per share. Equities analysts predict that USANA Health Sciences, Inc. will post $3.79 EPS for the current fiscal year.

USANA Health Sciences announced that its board has authorized a stock repurchase plan on Tuesday, July 25th that permits the company to repurchase $64.60 million in shares. This repurchase authorization permits the company to repurchase up to 46% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: “USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 28,788 Shares of Stock” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.thecerbatgem.com/2017/09/16/usana-health-sciences-inc-usna-director-myron-w-wentz-sells-28788-shares-of-stock.html.

Several brokerages have commented on USNA. BidaskClub upgraded shares of USANA Health Sciences from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 22nd. Pivotal Research reduced their target price on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating on the stock in a research report on Wednesday, July 26th.

Several hedge funds have recently added to or reduced their stakes in the stock. USA Financial Portformulas Corp bought a new stake in shares of USANA Health Sciences in the second quarter valued at about $691,000. Phocas Financial Corp. raised its holdings in shares of USANA Health Sciences by 4.7% in the second quarter. Phocas Financial Corp. now owns 125,090 shares of the company’s stock valued at $8,018,000 after acquiring an additional 5,575 shares in the last quarter. California State Teachers Retirement System raised its holdings in shares of USANA Health Sciences by 0.5% in the second quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock valued at $1,319,000 after acquiring an additional 100 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of USANA Health Sciences by 7.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,137 shares of the company’s stock valued at $586,000 after acquiring an additional 616 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of USANA Health Sciences by 711.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 91,409 shares of the company’s stock valued at $5,859,000 after acquiring an additional 80,145 shares in the last quarter. Hedge funds and other institutional investors own 44.90% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Stock Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related stocks with our FREE daily email newsletter.